Litcius/Paper detail

Thymoquinone Prevents Dopaminergic Neurodegeneration by Attenuating Oxidative Stress Via the Nrf2/ARE Pathway

Jianjian Dong, Xiaoming Zhang, Shijing Wang, Chenchen Xu, Manli Gao, Songyang Liu, Xiaoxiao Li, Nan Cheng, Yongsheng Han, Yongsheng Han, Xun Wang, Yongzhu Han, Yongzhu Han

2021Frontiers in Pharmacology51 citationsDOIOpen Access PDF

Abstract

Studies have indicated that oxidative stress plays a crucial role in the development of Parkinson’s disease (PD) and other neurodegenerative conditions. Research has also revealed that nuclear factor erythroid 2-related factor 2 (Nrf2) triggers the expression of antioxidant genes via a series of antioxidant response elements (AREs), thus preventing oxidative stress. Thymoquinone (TQ) is the bioactive component of Nigella sativa , a medicinal plant that exhibits antioxidant and neuroprotective effects. In the present study we examined whether TQ alleviates in vivo and in vitro neurodegeneration induced by 1-methyl-4-phenylpyridinium (MPP + ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by acting as an activator of the Nrf2/ARE cascade. We showed that TQ significantly reduced MPP + -mediated cell death and apoptosis. Moreover, TQ significantly elevated the nuclear translocation of Nrf2 and significantly increased the subsequent expression of antioxidative genes such as Heme oxygenase 1 (HO-1), quinone oxidoreductase (NQO1) and Glutathione-S-Transferase (GST). The application of siRNA to silence Nrf2 led to an abolishment in the protective effects of TQ. We also found that the intraperitoneal injection of TQ into a rodent model of PD ameliorated oxidative stress and effectively mitigated nigrostriatal dopaminergic degeneration by activating the Nrf2-ARE pathway. However, these effects were inhibited by the injection of a lentivirus wrapped Nrf2 siRNA (siNrf2). Collectively, these findings suggest that TQ alleviates progressive dopaminergic neuropathology by activating the Nrf2/ARE signaling cascade and by attenuating oxidative stress, thus demonstrating that TQ is a potential novel drug candidate for the treatment of PD.

Topics & Concepts

ThymoquinoneOxidative stressNeuroprotectionPharmacologyNeurodegenerationChemistryMPTPDopaminergicKEAP1AntioxidantBiochemistryBiologyMedicineInternal medicineTranscription factorDopamineEndocrinologyGeneDiseaseNigella sativa pharmacological applicationsAluminum toxicity and tolerance in plants and animalsBioactive Compounds and Antitumor Agents